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Acute weakness associated with West Nile virus
(WNV) infection has previously been attributed to a periph-
eral demyelinating process (Guillain-Barré syndrome);
however, the exact etiology of this acute flaccid paralysis
has not been systematically assessed. To thoroughly
describe the clinical, laboratory, and electrodiagnostic fea-
tures of this paralysis syndrome, we evaluated acute flac-
cid paralysis that developed in seven patients in the setting
of acute WNV infection, consecutively identified in four hos-
pitals in St. Tammany Parish and New Orleans, Louisiana,
and Jackson, Mississippi. All patients had acute onset of
asymmetric weakness and areflexia but no sensory abnor-
malities. Clinical and electrodiagnostic data suggested the
involvement of spinal anterior horn cells, resulting in a
poliomyelitis-like syndrome. In areas in which transmission
is occurring, WNV infection should be considered in
patients with acute flaccid paralysis. Recognition that such
weakness may be of spinal origin may prevent inappropri-
ate treatment and diagnostic testing.
M
ost human infections with West Nile virus (WNV), a
flavivirus within the Japanese encephalitis virus
antigenic complex, are clinically inapparent (1,2). Mild
febrile illness develops in approximately 1 in 5 infected
persons; more severe neurologic disease, mostly meningi-
tis or encephalitis, occurs in and 1 in 150 (1–4). Less fre-
quently, acute WNV infection has been associated with
acute flaccid paralysis, which has been attributed to
Guillain-Barré syndrome, motor axonopathy, or axonal
polyneuropathy (4–6). However, these reports describe
clinical and laboratory features that seem inconsistent with
such diagnoses, and the exact cause of acute flaccid paral-
ysis has not been thoroughly assessed with rigorous elec-
trophysiologic, laboratory, and neuroimaging data. Brief
descriptions of six patients have suggested that this flaccid
paralysis is due to anterior horn cell involvement with a
resultant poliomyelitis-like syndrome (7–9). Because
understanding the clinical characteristics and underlying
etiology of WNV-induced acute flaccid paralysis is critical
for therapeutic decisions as well as prognosis, we describe
the detailed clinical, laboratory, and electrophysiologic
findings from these six patients and from one additional
patient. 
Patients and Methods
Seven patients were detected through WNV surveil-
lance conducted by the Mississippi Department of Health
and the Louisiana Office of Public Health. For each
patient, a standardized questionnaire, including demo-
graphics, medical history, initial signs and symptoms, risk
factors, and treatment, was completed; a standardized neu-
rologic examination was performed by a single neurologist
(JJS). Electrodiagnostic studies were performed by neurol-
ogists (AAL and JAVG) specializing in electrodiagnostic
medicine. 
Cerebrospinal fluid (CSF) and acute- or convalescent-
phase serum specimens (or both) from each patient were
tested for antibody to WNV by immunoglobulin (Ig) M
antibody-capture enzyme immunoassay (10) or plaque
reduction neutralization assay (11). The initial specimen
for one patient (patient 5, Table 1) was tested with a slight-
ly modified IgM antibody assay at a commercial laborato-
ry (12). IgM assays were considered positive if the optical
density ratio of the patient and negative control samples
(P/N ratio) was greater than three. For patient samples, a
P/N ratio for WNV at least three times that for St. Louis
encephalitis virus indicated WNV infection (13). A plaque
reduction neutralization test result of at least 10 was con-
sidered positive.
All seven patients had serologic evidence of WNV infec-
tion (Table 1). On the basis of serologic data, three of the
patients were classified as confirmed case-patients (patients
4, 6, and 7) and four as probable case-patients (patients 1–3,
5), according to the national case definition (14).
Case 1 
On July 1, 2002, a previously healthy, 56-year-old,
male Mississippi resident was hospitalized with a 1-week
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USAhistory of fever, chills, night sweats, myalgias, and acute
encephalopathy. Neurologic examination showed pro-
found weakness in both arms, asymmetric weakness in the
legs with a right foot drop, and acute respiratory distress
(Table 2). Sensory test results were normal. Although com-
puted tomography (CT) and magnetic resonance imaging
(MRI) of the brain showed normal results, heparin was
administered for suspected evolving stroke. Admission
laboratory values (Table 3) showed serum leukocytosis,
and cerebrospinal fluid (CSF) obtained on day 3 showed
elevated protein. By day 8, Guillain-Barré syndrome was
suspected, and intravenous immunoglobulin (IVIG) was
administered. Electrodiagnostic studies performed that day
were interpreted as showing a proximal neuropathy or
myopathy. A deltoid muscle biopsy for suspected inflam-
matory myopathy showed mild type 2 fiber atrophy but no
obvious necrosis or marked inflammatory response. On
day 30, the patient was transferred for rehabilitation with
flaccid, areflexic paralysis in the right leg and variable
weakness and diminished reflexes in all other limbs. Neck
flexors were normal in strength, and sensation was pre-
served in all limbs; loss of bladder function was evident.
MRI of the cervical spine showed normal results.
Electrodiagnostic studies showed widespread but variable
denervation, reduced compound muscle action potentials
(CMAPs), and normal sensory nerve action potentials
(SNAPs), consistent with a severe, asymmetric process
affecting anterior horn cells or motor axons. Myopathy,
demyelinating polyneuropathy, and diffuse axonal
polyneuropathy were not evident. 
Case 2 
On July 15, 2002, a 57-year-old male Mississippi resi-
dent with a remote history of prostate cancer and glucose
intolerance was hospitalized with a 3-day history of fever,
chills, nausea, vomiting, and headache. Neurologic exam-
ination showed encephalopathy and asymmetric weakness
in all limbs (Table 2). Results of a brain MRI weree nor-
mal. Admission laboratory studies showed a CSF pleocy-
tosis with elevated protein (Table 3). On day 5, acute res-
piratory distress developed, and the patient required
mechanical ventilation. Upon extubation 2 weeks later, the
patient had continued extremity weakness and was aspirat-
ing fluids; a modified barium swallow study showed
oropharyngeal dysphagia. Upon transfer to a rehabilitation
center on day 30, the patient had asymmetric weakness in
the legs and right arm and moderate weakness in neck flex-
ors and facial muscles. Hypotonia and areflexia were noted
in all limbs. Sensation was slightly diminished to vibration
and proprioception in toes bilaterally but preserved to light
touch, pinprick, and temperature. Sensory testing was nor-
mal in the upper limbs. Urinary incontinence was noted.
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Table 1. Serologic results for West Nile virus (WNV)–specific antibodies in patients with acute flaccid paralysis associated with acute 
WNV infection
a 
        IgM-capture enzyme immunoassay  Plaque reduction neutralization assay 
Case no.  Onset  Collection  Sample  SLEV  WNV  SLEV  WNV 
1  6/24  7/12  Serum  3.5  22.3  320  5,120 
2  7/12  7/16  Serum  8.0  22.7  80  1,280 
3  7/26  8/1  Serum  2.79  24.9  <10  640 
4  7/29  8/3  Serum  1.1  14.1  <10  80 
4  7/29  8/3  CSF  3.3  39.2     
4  7/29  8/13  Serum  4.4  23.5  40  2,560 
5  8/11  8/15  Serum    2.02     
5  8/11  8/29  Serum  3.4  25.7     
6  8/13  8/16  CSF  6.1  23.8     
6  8/13  8/16  Serum  1.0  5.7  <10  40 
7  9/1  10/24  Serum  2.8  10.6  10  320 
7  9/1  9/6  CSF  Not performed  7.4     
aIgM, immunoglobulin M; SLEV, Saint Louis encephalitis virus; CSF, cerebrospinal fluid. 
Table 2. Initial clinical signs and symptoms in patients with acute flaccid paralysis associated with acute West Nile virus infection 
Case no.  Fever (>38.5°C)  Headache  Nuchal rigidity  Altered mental status  Tremor  Distribution of weakness
a 
1  +  +  +  +  +  Upper and lower limbs, R > L 
2  +  +  -  +  -  Upper and lower limbs, R > L 
3  +  -  -  -  +  Lower limbs, R > L 
4  +  +  +  +  +  R upper limb 
5  -  +  -  -  -  R upper limb 
6  +  +  -  -  +  Lower limbs, R > L 
7  +  +  +  -  -  Upper and lower limbs, L > R;  
bulbar muscles 
aR, right; L, left. Electrodiagnostic studies showed widespread denervation,
reduced CMAPamplitudes in all nerves of the lower limbs
and right upper limb, and normal SNAP responses, consis-
tent with a severe, asymmetric process affecting anterior
horn cells or motor axons. Myopathy, demyelinating
polyneuropathy, and diffuse axonal polyneuropathy were
not apparent.
Case 3
On July 24, 2002, a low-grade fever, nausea, and vom-
iting, followed by shaking chills and sweats, developed in
a 56-year-old male Louisiana resident with a history of
hypertension and coronary artery disease. The next day,
asymmetric weakness developed in the lower extremities,
with no pain or numbness. Upper extremities were normal.
No bowel or bladder dysfunction was present. The patient
was hospitalized on July 29, and neurologic examination
showed a flaccid, areflexic right lower extremity and a
weak left lower extremity with diminished reflexes.
Results of strength and reflex testing of the upper extrem-
ities were normal. Sensory examination results were nor-
mal except for a mild decrease in sensitivity to pinprick,
temperature, touch, and vibration in a stocking-and-glove
distribution (i.e., distal arms and legs). A coarse bilateral
upper extremity action tremor was noted. The patient had
no headache, neck stiffness, or alteration of mental status
(Table 2). Admission laboratory values showed leukocyto-
sis and CSF pleocytosis (Table 3). Results of other diag-
nostic tests were unremarkable. Postviral demyelination
syndrome and viral-induced polyradicultis were consid-
ered, and IVIG,  dexamethasone, and antibacterial and
antiviral medications were administered without patient
improvement. On day 15, the patient was discharged to a
skilled nursing facility for rehabilitation.
MRI of the cervical, thoracic, and lumbosacral spine
obtained during rehabilitation was notable for showing
mild cervical and lumbosacral spinal stenosis and forami-
nal restrictions from C3 through C7 and homogeneous
enhancement of the nerve roots of the cauda equina consis-
tent with meningitis. Electrodiagnostic studies showed
denervation in thoracic and lumbosacral myotomes, with
no muscle activation in the right leg and reduced muscle
activation in the left leg. CMAPs in the right leg were
absent; SNAPs were normal. Electrodiagnostic findings
suggested a severe, asymmetric process affecting anterior
horn cells or motor axons. Diffuse axonal polyneuropathy
was not evident, despite a slight sensory loss in the distal
extremities. 
Case 4 
On August 2, 2002, fever, headache, and neck stiffness
developed in a 69-year-old female Louisiana resident with
a history of diabetes and degenerative disc disease; the
next day acute weakness occurred in the right arm without
pain, numbness, or paresthesias. She was hospitalized on
August 4. On admission, physical examination document-
ed fever, vomiting, encephalopathy, nuchal rigidity, and a
bilateral rash on the lower extremities. Neurologic exam-
ination displayed a flaccid and areflexic right arm. Her
legs and left arm exhibited normal strength, reflexes, and
coordination, with normal sensation in all limbs. A coarse
tremor was noted in the chin, left arm, and legs (Table 2).
Laboratory findings included CSF pleocytosis (Table 3).
Differential diagnoses included meningoencephalitis with
associated motor polyradiculopathy and monoplegia sec-
ondary to stroke. The patient was treated with antibacter-
ial and antiviral medications. Results of CT and MRI of
the brain were normal. MRI of the cervical spine showed
multilevel degenerative disc disease. The patient
remained lethargic until day 13, when mental status
abruptly improved; right arm weakness persisted. On day
19, she was transferred to a rehabilitation facility.
Electrodiagnostic studies showed absent CMAPs and pro-
found denervation with no voluntary activation in muscles
of the right arm. Scattered denervation was also seen in
the other three limbs. SNAPs had borderline amplitudes
and conduction velocities bilaterally. The results were
most consistent with a severe, asymmetric process affect-
ing anterior horn cells or motor axons. The patient was
subsequently transferred back to intensive care because
her respiratory function was deteriorating, but she was not
intubated. After Guillain-Barré syndrome was diagnosed,
she was started on IVIG but had no improvement in
weakness.
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1  17.6   38.0  3  1,778  89  54 
2  3.6   38.2  2,600   87  204  99 
3  11.8   44.4  140  40  234  74 
4  9.5   37.8  143  4  116  119 
5  7.9   45.6  Not performed  Not performed  Not performed  Not performed 
6  13.0   45.4  329  7  75  66 
7  10.3   Not performed  182  9  37  79 
aCSF, cerebrospinal fluid; WBC, leukocyte count; RBC, erythrocyte count. Case 5
On August 11, 2002, severe nausea, vomiting,
headache, and diarrhea in the absence of fever developed
in a 50-year-old male Mississippi resident with a history of
alcohol abuse; the next day, progressive right arm weak-
ness developed. He was hospitalized on August 14.
Neurologic examination on admission showed flaccid
paralysis of the right arm and mild weakness of the right
leg, with normal sensation in all limbs (Table 2).
Laboratory values are shown in Table 3; a lumbar puncture
was not performed. Acute stroke was diagnosed, and the
patient was treated with heparin. Mental status changes,
dysarthria, and dysphagia subsequently developed but
resolved. Upon transfer to a rehabilitation center on day
12, the patient had paralysis and areflexia limited to the
right arm, with normal sensation and diffuse tremor in all
limbs. Brain MRI results were normal; cervical spine MRI
displayed mild multilevel foraminal stenosis on the left.
Electrodiagnostic studies showed markedly reduced motor
responses in the right arm with normal sensory responses,
consistent with a severe asymmetric process affecting
anterior horn cells. 
Case 6
On August 16, 2002, a 46-year-old male Louisiana res-
ident with a history of coronary artery disease was hospi-
talized with fever, headache, fatigue, and leg weakness of
3 days’ duration. He reported no nuchal rigidity or mental
status changes, although family members described him as
intermittently confused. Neurologic examination showed a
plegic and areflexic right leg and mild left leg weakness;
sensation was intact throughout. A bilateral tremor of the
upper extremities and jaw was noted (Table 2). Laboratory
abnormalities included a CSF pleocytosis (Table 3). He
was diagnosed with Guillain-Barré syndrome and started
on IVIG. Brain CT and MRI results were normal. Results
of an enhanced MRI of the spine suggested meningitis
involving the conus medullaris and cauda equina.
Electrodiagnostic studies performed on day 4 demonstrat-
ed early denervation and absent activation in muscles of
the right leg and reduced activation of muscles in the right
arm. CMAPs and SNAPs in the right arm and leg were
normal. These findings were consistent with a severe,
asymmetric process affecting anterior horn cells or motor
axons. He was transferred to a rehabilitation facility on day
6 with no improvement of weakness.
Case 7 
On September 1, 2002, a previously healthy, 39-year-
old male Louisiana resident had onset of fever, headache,
and nuchal rigidity followed the next day by dysphagia and
bilateral arm and leg weakness that was worse on the left.
He was hospitalized on September 6 for acute respiratory
failure and intubated. Neurologic examination showed
normal cognition, asymmetric flaccid paralysis of the left
arm and leg with absent reflexes, hyporeflexic weakness of
the right arm and leg, and weakness of bulbar muscles
(Table 2). A partial supranuclear gaze palsy, cogwheel
rigidity, and bilateral Babinski signs were also evident.
Admission laboratory findings showed peripheral leukocy-
tosis and CSF pleocytosis (Table 3). Brain MRI showed
increased T2 signal in the periaqueductal gray matter, sub-
stantia nigra, and trigeminal motor nuclei.
Electrodiagnostic studies performed on day 15 showed dif-
fuse denervation in all myotomes, reduced CMAPs (worse
on the left), and preserved SNAPs. On day 25, he was
transferred to a long-term care facility with no improve-
ment of limb weakness.
Discussion
The clinical and electrodiagnostic findings in these
patients with WNV infection suggest involvement of
spinal cord gray matter, specifically anterior horn cells,
and a resulting acute poliomyelitis-like syndrome. All
patients exhibited features typical for polio, including
acute flaccid paralysis without paresthesias or sensory
loss, marked asymmetric weakness, diminished or absent
deep tendon reflexes in the affected limbs, and weakness
that developed during an acute infectious process. Other
typical features of poliomyelitis included CSF pleocytosis
in five of six patients with CSF examination, acute respi-
ratory distress in four, and acute changes in bowel or blad-
der function in two. In addition, electrodiagnostic findings
showed asymmetric muscle denervation, reduced CMAPs,
and preserved SNAPs. No patients had evidence of
demyelinating polyneuropathy or myopathy. The absence
of new sensory abnormalities localizes the disease process
to the anterior horn cells or motor axons. Although muscle
denervation and reduced CMAP amplitudes do not distin-
guish loss of anterior horn cells from loss of motor axons
(15), these patients’clinical features can be explained only
by anterior horn cell disease, since no known infectious
processes limited to motor axons produce widespread,
asymmetric paralysis without sensory involvement. While
MRI signal abnormalities in the anterior spinal cord have
been noted in patients with poliomyelitis (16,17), these
findings are inconsistent (18,19), and the absence of such
changes in our four patients in which imaging was per-
formed does not preclude a diagnosis of a poliomyelitis-
like syndrome.
Since immunization has eradicated wild-type
poliovirus from the developed world, most cases of para-
lytic polio-like conditions in the United States have been
linked to other RNA viruses, including echoviruses,
enteroviruses, and coxsackieviruses (20). Case reports
have documented a poliomyelitis-type syndrome associat-
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myelitis associated with WNV infection (24).
The assertion that WNV infection involves anterior
horn cells and causes a polio-type syndrome has a patho-
logic basis. The neuropathology of experimental WNV
infection in monkeys was most pronounced in the cerebel-
lum, medulla, and the cervical and lumbar regions of the
spinal cord (25). Anterior horn cells showed degeneration
and neuronal cell death; conversely, no changes were seen
in the oligodendroglia or peripheral nerves. Similarly,
WNV-infected horses displayed multifocal polioen-
cephalomyelitis, with involvement of the ventral and later-
al horns of the thoracic and lumbar spinal cord (26,27).
WNV antigen was mainly localized within the gray matter
of the spinal cord, with no lesions apparent in peripheral
nerves or ganglia. In WNV-infected birds, lesions and viral
antigen were most prominent in the cerebellum and the
gray matter of the spinal cord (28). 
Previous case studies have attributed WNV-associated
acute flaccid paralysis to Guillain-Barré syndrome, motor
axonopathy, or severe axonal polyneuropathy (4–6). The
clinical signs and symptoms and electrodiagnostic findings
reported in those cases, and those described here, are most
consistent with a polio-like condition, and would be atypi-
cal for Guillain-Barré syndrome or other peripheral nerve
disorders. Although acute poliomyelitis and polio-like con-
ditions may occasionally simulate Guillain-Barré syn-
drome (29), our cases had several clinical, laboratory, and
electrodiagnostic features that differed from typical
Guillain-Barré syndrome (30–32; Table 4). 
In Guillain-Barré syndrome, electrodiagnostic findings
generally suggest peripheral nerve demyelination or, less
commonly, a combined demyelinating and axonal process
(30,31). The cases reported here displayed reduced or
absent CMAPs with preserved SNAPs, no evidence of
demyelination, a neurogenic pattern of recruitment, and
widespread denervation; combined with the clinical pic-
ture of an asymmetric paralysis, these findings are typical
for a polio-like condition and uncommon for Guillain-
Barré syndrome. A pure axonal variant of Guillain-Barré
syndrome has been described (33) and may be confused
with poliomyelitis and polio-like conditions; however,
such cases are generally characterized by distally promi-
nent weakness and show subclinical sensory nerve
involvement on electrodiagnostic testing. Thus, in the con-
text of WNV infection, electrodiagnostic studies previous-
ly interpreted as motor axonal polyneuropathy or motor
axonopathy without sensory nerve involvement (4–6) are
more suggestive of anterior horn cell loss than of Guillain-
Barré syndrome.
Three of the seven patients had acute flaccid paralysis
without other findings, suggestive of severe central nerv-
ous system involvement caused by WNV infection.
Physicians should suspect WNV infection in patients from
areas where WNV is being transmitted and who have
acute, painless, asymmetric weakness, even if unaccompa-
nied by fever or apparent meningoencephalitis. Diagnostic
studies should include testing for WNV-specific IgM anti-
body in CSF or acute- and convalescent-phase serum sam-
ples. In patients from such areas who have acute flaccid
paralysis, CSF analysis, thorough electrodiagnostic stud-
ies, and spinal imaging should be considered before initi-
ating diagnostic evaluations or therapies directed at
Guillain-Barré syndrome, stroke, inflammatory
myopathies, or other peripheral inflammatory processes.
These therapies are ineffective for polio-like syndromes
and can produce serious sequelae (34–37). 
Continued surveillance and investigation of WNV-
infected patients are needed to fully define the scope of
clinical illness and determine the incidence of acute flaccid
paralysis. In addition to assessing clinical outcome, the
identification of risk factors and the pathologic confirma-
tion of anterior horn cell involvement in patients with
WNV-associated acute flaccid paralysis remain important
public health goals.
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Table 4. Clinical characteristics of patients with West Nile virus–associated acute flaccid paralysis compared with patients with typical 
Guillain-Barré syndrome (25–27)
a 
Characteristic  West Nile virus–associated flaccid paralysis  Guillain-Barré syndrome 
Timing of onset  Acute phase of infection  1–8 weeks after acute infection 
Fever and leukocytosis  Present  Absent 
Weakness distribution  Asymmetric; occasional monoplegia  Generally symmetric; proximal and distal muscles 
Sensory symptoms  Absence of numbness, paresthesias, or  
sensory loss; occasional myalgias 
Painful distal paresthesias and sensory loss 
Bowel/bladder involvement  Often present  Rare 
Concurrent encephalopathy  Often present  Absent 
CSF profile  Pleocytosis and elevated protein  No pleocytosis; elevated protein  
(albuminocytologic dissociation) 
Electrodiagnostic features  Anterior horn cell/motor axon: reduced/absent 
CMAPs, preserved SNAPs; asymmetric denervation 
Demyelination: marked slowing of conduction velocity; 
conduction block, temporal dispersion; reduced SNAPs 
aCSF, cerebrospinal fluid; CMAPs, compound muscle action potentials; SNAPSs, sensory nerve action potentials. Acknowledgments
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